Transparency Market Research Single User License: Continuous Glucose USD 4595 Monitoring Market - Global Multi User License: Industry Analysis, Size, USD 7595 Share, Growth, Trends and Corporate User License: USD 10595 Forecast, 2013 – 2019
Published Date
68 Page Report
06-March-2014
Buy Now
Request Sample
Press Release
Continuous Glucose Monitoring Market Expected to Reach USD 0.91 Billion Globally in 2019: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Continuous Glucose Monitoring Market
REPORT DESCRIPTION
According to a new market report published by Transparency Market Research "Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global continuous glucose monitoring market was valued at USD 0.37 billion in 2012 and is expected to grow at a CAGR of 13.6% from 2013 to 2019, to reach an estimated value of USD 0.91 billion in 2019. Browse the Continuous Glucose Monitoring Market Report with Full TOC at http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html Continuous glucose monitoring systems (CGMS) are real time glucose monitoring devices that measure and display the glucose level of the interstitial fluid in the skin cells of the patient. These devices help patients manage diabetes (Type 1 and Type 2) in a more efficient manner. CGM devices typically comprise a sensor, transmitter and a receiver. The sensor is placed underneath the skin for monitoring glucose levels and is attached to the transmitter that relays the information to the monitor. Until recently, management of diabetes involved the use of conventional blood glucose meters that provided a single time snapshot of the patient's blood glucose level. However, demand for real time monitoring, minimally invasive and effective diabetes management solutions led to the advent of CGM devices. Rise in the incidence of diabetes globally coupled with increasing awareness of such devices that possess the ability to detect hyper and hypoglycemic events in real time will fuel the growth of this market during the forecast period. Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1169 CGM is a rapidly evolving market supported by increasing adoption of these systems by hospitals and individual practitioners who further encourage their patients to use these devices. However, CGM systems are not meant to be replaced by the traditional diabetes management devices. Hence, the technology still requires innovation in terms of accuracy and precision. Reimbursement issues, high cost of devices and low market penetration rates are some of the factors that are expected to hinder market growth in the near future. Medtronic's Guardian Real Time CGM System accounted for the largest share of the global marketin 2012, accounting for a share of over 40%. The product's first mover advantage in the market, proper positioning and marketing of the product, and ease of convenience and usability helped it achieve this leadership position. Dexcom's fourth generation product, namely, Dexcom G4 Platinum is anticipated to witness the highest market growth at a CAGR of 22.6% during the forecast period. G4 Platinum is the most recently launched device (2012) and is the most technologically advanced, offering more accuracy and reliability as compared to other commercially available devices. In addition, integration of this device with insulin pumps from various other manufacturers like Johnson & Johnson and Tandem Diabetes Care would also drive the growth of this market segment.
2 Transparency Market Research
Continuous Glucose Monitoring Market
Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html Geographically, North America captured majority share of the global continuous glucose monitoring market in 2012. Increase in type I diabetic population along with rise in geriatric population which will in turn spur the demand for regular monitoring of glucose levels will fuel the growth of this market. Major players of this market are domiciled in this region, which allows easy market penetration and will also contribute towards market growth. The European CGM market is in a rapidly evolving state and contributed the largest share of the total CGM market revenue in 2012. Asia-Pacific is expected to witness tremendous increase its market share and emerge as the fastest growing region, reporting a CAGR of 16.9% during the forecast period. Economic developments, presence of a large patient pool, rising patient awareness, increasing disposable income and changing lifestyle are some of the significant factors that are poised to increase the demand for CGM systems in this region. Key players in this market include Medtronic, Inc., Dexcom, Inc. and Abbott Diabetes Care. Medtronic was the leading player of this market in 2012, accounting for a share of over 50%. Abbott saw a decline in its market share due to withdrawal of Free Style Navigator from the U.S. market in the fourth quarter of 2011. However, the expected launch of Free Style Navigator ll in 2014 in the U.S. market would help the company restore its market position. Other companies such as Johnson & Johnson, Bayer Healthcare and Tandem Diabetes Care are adopting the strategy of partnerships and collaboration to enter this dynamic market.
TABLE OF CONTENT
Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.3.1.1 Secondary Research 1.3.1.2 Primary Research 1.3.2 Assumptions
3 Transparency Market Research
Continuous Glucose Monitoring Market
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019) 2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Rise in diabetic population globally 3.2.2 Rise in demand for point of care testing (POCT) 3.3 Market Restraints 3.3.1 Unfavourable reimbursement policies 3.3.2 Calibration issues 3.4 Market Opportunities 3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques 3.5 Porter’s Five Forces Analysis for the Global Continuous Glucose Monitoring Market 3.5.1 Bargaining power of suppliers 3.5.2 Bargaining power of buyers 3.5.3 Threat of substitutes 3.5.4 Threat of new entrants 3.5.5 Competitive Rivalry
4 Transparency Market Research
Continuous Glucose Monitoring Market
3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
Browse the Continuous Glucose Monitoring Market Report with Full TOC at http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html
Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 – 2019 (USD Million) 4.1 Overview 4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million) 4.2 Guardian Real Time CGM System 4.2.1 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million) 4.3 FreeStyle Navigator 4.3.1 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million) 4.4 Dexcom Seven Plus CGM System 4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million) 4.5 Dexcom G4 Platinum 4.5.1 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million) 4.6 MiniMed Paradigm Revel/Veo System 4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million) 4.7 Others 4.7.1 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
5 Transparency Market Research
Continuous Glucose Monitoring Market
Chapter 5 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million) 5.1 Overview 5.1.1 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million) 5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million) 5.3 Europe 5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
Chapter 6 Competitive Landscape 6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market 6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
6 Transparency Market Research
Continuous Glucose Monitoring Market
Chapter 7 Recommendations 7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa 7.2 Investing in research and development of technologically advanced products with added benefits 7.3 Emphasis on price control
Browse the Continuous Glucose Monitoring Market Report with Full TOC at http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html
Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Bayer AG 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments
7 Transparency Market Research
Continuous Glucose Monitoring Market
8.3 Dexcom, Inc. 8.3.1 Company overview 8.3.2 Financial overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 GlySens Incorporated 8.4.1 Company overview 8.4.2 Product Portfolio 8.4.3 Business Strategies 8.5 Insulet Corporation 8.5.1 Company overview 8.5.2 Financial overview 8.5.3 Product portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Medtronic, Inc. 8.6.1 Business Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies
8 Transparency Market Research
Continuous Glucose Monitoring Market
8.6.5 Recent Development
Browse the Continuous Glucose Monitoring Market Report with Full TOC at http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html
8.7 Nova Biomedical Corporation 8.7.1 Company overview 8.7.2 Product portfolio 8.7.3 Business Strategies 8.7.4 Recent Developments 8.8 Senseonics, Incorporated 8.8.1 Company overview 8.8.2 Product portfolio 8.8.3 Business Strategies 8.8.4 Recent Developments
About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our
9 Transparency Market Research
Continuous Glucose Monitoring Market
business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Blog: http://tmrresearch.wordpress.com/
10 Transparency Market Research